Skip to Main Content
OUTSOURCE EVERYTHING BUT THE GENIUS™

Welcome, Guest.

Go to Main Navigation

Outsourcing

Showing 11 - 20 of 55 posts
Feb 26, 2014

Previously, we discussed in part 1 of this series the growing significance of computational methods in drug discovery. Traditional drug discovery...

Feb 18, 2014

Traditional drug discovery is expensive, inefficient, and has huge barriers to entry. Big pharmaceutical companies continue to struggle to cope...

Jan 23, 2014

This is Part 3 in a three-part series on Big Data in the pharma and biotech industries. (Check out Part 1 and Part 2). Big Data — the vast...

Dec 31, 2013

The need for CNS therapeutics is on the rise. Neurological diseases are expected to increase steadily in the coming years. Previously, we addressed...

Nov 12, 2013

This is Part 3 in a three-part series on key factors in CRO selection. (Check out Part 1 and Part 2). Use of CROs in research and drug...

Nov 7, 2013

This is Part 2 in a three-part series on key factors in CRO selection. (Check out Part 1 and Part 3). Contract research organizations (CROs...

Oct 29, 2013

Kevin Lustig was invited by The Empowered Patient Radio Show after they heard Kevin at the Tech Coast Angels quick pitch competition. Kevin...

Oct 24, 2013

This is Part 1 in a three-part series on key factors in CRO selection. (Check out Part 2 and Part 3). Alternative strategies for approaching...

Oct 22, 2013

The next time your research takes you outside your field of expertise, you might consider looking for a core lab to help move your project forward...

Oct 10, 2013

Core labs are important assets to academic institutions. They are concentrated pockets of experts, to whom scientists can outsource specific parts...